Reference
Lim SL, et al. Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy. Gynecologic Oncology : Feb 2019. Available from: URL: http://doi.org/10.1016/j.ygyno.2019.01.025
Rights and permissions
About this article
Cite this article
Hyperthermic IP chemotherapy in ovarian cancer cost effective. PharmacoEcon Outcomes News 822, 14 (2019). https://doi.org/10.1007/s40274-019-5666-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5666-3